As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedelic studies is remarkable.
The agency annually invests about $41.7 billion in medical research as a whole, while more than 80 percent of the funding is awarded for extramural research through 50,000 competitive grants to researchers at universities, medical schools and other research institutions.
